UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

Circulation (New York, N.Y.), 1999-12, Vol.100 (25), p.2477-2484

1999

Volltextzugriff (PDF)

Prevalence of the metabolic syndrome in American adolescents: Findings from the Third National Health and nutrition examination survey

Circulation (New York, N.Y.), 2004-10, Vol.110 (16), p.2494-2497

2004

Volltextzugriff (PDF)

Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: Results from a Department of Veterans Affairs Cooperative Study

Journal of the American College of Cardiology, 2004-12, Vol.44 (11), p.2149-2156

2004

Volltextzugriff (PDF)

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

The American heart journal, 2009-09, Vol.158 (3), p.356-363

2009

Volltextzugriff (PDF)

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker integrelin in elective coronary intervention

Circulation (New York, N.Y.), 1995-04, Vol.91 (8), p.2151-2157

1995

Volltextzugriff (PDF)

Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: The integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial

Journal of the American College of Cardiology, 2002-02, Vol.39 (3), p.377-386

2002

Volltextzugriff (PDF)

Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study)

Circulation (New York, N.Y.), 1999-08, Vol.100 (8), p.799-806

1999

Volltextzugriff (PDF)

Single-pill amlodipine atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study)

Journal of human hypertension, 2009-03, Vol.23 (3), p.196-210

2009

Volltextzugriff (PDF)

Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study : performance of a noninvasive method for real-time detection of failed myocardial reperfusion

Circulation (New York, N.Y.), 1993-08, Vol.88 (2), p.437-446

1993

Volltextzugriff (PDF)

Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six-month follow up and analysis of individual patient data from randomized trials

The American heart journal, 2003, Vol.145 (1), p.47-57

2003

Volltextzugriff (PDF)

Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) Trial

Journal of the American College of Cardiology, 1998-12, Vol.32 (7), p.2003-2010

The Paradigm Investigators

1998

Volltextzugriff (PDF)

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction

Circulation (New York, N.Y.), 1990-09, Vol.82 (3), p.781-791

1990

Volltextzugriff (PDF)

Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction

The American heart journal, 1999-04, Vol.137 (4), p.612-620

1999

Volltextzugriff (PDF)

Pneumonectomy for stage i (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival

The Annals of thoracic surgery, 2003-10, Vol.76 (4), p.1023-1028

2003

Volltextzugriff (PDF)

Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures: Statement of the american college of cardiology

Journal of the American College of Cardiology, 1998-03, Vol.31 (3), p.722-743

1998

Volltextzugriff (PDF)

A randomized trial of late reperfusion therapy for acute myocardial infarction

Circulation (New York, N.Y.), 1992-06, Vol.85 (6), p.2090-2099

1992

Volltextzugriff (PDF)

Multivessel coronary artery disease: A key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction

The American heart journal, 1991-04, Vol.121 (4), p.1042-1049

1991

Volltextzugriff (PDF)

Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomy

Circulation (New York, N.Y.), 1991-08, Vol.84 (2), p.644-653

1991

Volltextzugriff (PDF)

In-hospital cost of percutaneous coronary revascularization : critical determinants and implications

Circulation (New York, N.Y.), 1995-08, Vol.92 (4), p.741-747

1995

Volltextzugriff (PDF)

Recurrent ischemia without warning: analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator

Circulation (New York, N.Y.), 1989-11, Vol.80 (5), p.1159-1165

1989

Volltextzugriff (PDF)

Thrombolytic therapy for women with myocardial infarction: Is there a gender gap?

Journal of the American College of Cardiology, 1993-12, Vol.22 (7), p.1780-1787

1993

Volltextzugriff (PDF)

Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials)

The American journal of cardiology, 1995-05, Vol.75 (14), p.871-876

1995

Volltextzugriff (PDF)

Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction

The American heart journal, 1990-02, Vol.119 (2), p.224-231

1990

Volltextzugriff (PDF)

Assessment of the safety and efficacy of the DUETT vascular hemostasis device: Final results of the safe and effective vascular hemostasis (SEAL) trial

The American heart journal, 2002-04, Vol.143 (4), p.612-619

The SEAL Trial Study Team

2002

Volltextzugriff (PDF)

Cost of cardiac care in the three years after coronary catheterization in a contained care system : Critical determinants and implications

Journal of the American College of Cardiology, 1998-05, Vol.31 (6), p.1306-1313

1998

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Nur zeigenMit Volltextzugriff

ThemaCardiovascular System & Cardiology

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(29)
Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Cardiac & Cardiovascular Systems
(28)
Humans
(19)
Male
(17)
Female
(16)
Middle Aged
(15)
Aged
(12)
Cardiology. Vascular System
(11)
Peripheral Vascular Disease
(11)
Pharmacology. Drug Treatments
(9)
Blood. Blood Coagulation. Reticuloendothelial System
(8)
Coronary Heart Disease
(8)
Heart
(8)
Treatment Outcome
(8)
Diseases Of The Cardiovascular System
(7)
Risk Factors
(7)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

Prevalence of the metabolic syndrome in American adolescents: Findings from the Third National Health and nutrition examination survey

Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: Results from a Department of Veterans Affairs Cooperative Study

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker integrelin in elective coronary intervention

Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: The integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial

Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study)

Single-pill amlodipine atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study)

Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study : performance of a noninvasive method for real-time detection of failed myocardial reperfusion

Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six-month follow up and analysis of individual patient data from randomized trials

Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) Trial

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction

Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction

Pneumonectomy for stage i (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival

Recommendations for the assessment and maintenance of proficiency in coronary interventional procedures: Statement of the american college of cardiology

A randomized trial of late reperfusion therapy for acute myocardial infarction

Multivessel coronary artery disease: A key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction

Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomy

In-hospital cost of percutaneous coronary revascularization : critical determinants and implications

Recurrent ischemia without warning: analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator

Thrombolytic therapy for women with myocardial infarction: Is there a gender gap?

Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials)

Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction

Assessment of the safety and efficacy of the DUETT vascular hemostasis device: Final results of the safe and effective vascular hemostasis (SEAL) trial

Cost of cardiac care in the three years after coronary catheterization in a contained care system : Critical determinants and implications

Aktive Filter

Suchergebnisse filtern